Abbvie (ABBV) PT Raised to $130 at Cowen After Winning Patent Challenge
Tweet Send to a Friend
Cowen analyst Steve Scala raised the price target on Abbvie (NYSE: ABBV) to $130.00 (from $120.00) after meeting with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
